Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Goodwill (2016 - 2022)

Sangamo Therapeutics (SGMO) has 10 years of Goodwill data on record, last reported at $37.6 million in Q4 2022.

  • For Q4 2022, Goodwill fell 5.42% year-over-year to $37.6 million; the TTM value through Dec 2022 reached $37.6 million, down 5.42%, while the annual FY2022 figure was $37.6 million, 5.42% down from the prior year.
  • Goodwill reached $37.6 million in Q4 2022 per SGMO's latest filing, up from $34.5 million in the prior quarter.
  • Across five years, Goodwill topped out at $42.8 million in Q4 2020 and bottomed at $1.6 million in Q1 2018.
  • Average Goodwill over 5 years is $32.7 million, with a median of $39.3 million recorded in 2019.
  • Peak YoY movement for Goodwill: soared 2426.44% in 2018, then decreased 14.85% in 2022.
  • A 5-year view of Goodwill shows it stood at $40.0 million in 2018, then dropped by 1.93% to $39.3 million in 2019, then rose by 8.98% to $42.8 million in 2020, then decreased by 7.23% to $39.7 million in 2021, then decreased by 5.42% to $37.6 million in 2022.
  • Per Business Quant database, its latest 3 readings for Goodwill were $37.6 million in Q4 2022, $34.5 million in Q3 2022, and $36.7 million in Q2 2022.